Catheter Precision enters ATM agreement to sell up to $1.3M of common stock

Catheter Precision, Inc.

ATM agreement with Ladenburg Thalmann allows sale of up to $1.3M of common stock on NYSE American.
Proceeds will be used for operations and working capital; company has no obligation to sell any shares.
Ladenburg receives 3.0% commission on gross proceeds; agreement ends upon sale of all shares or by 5-day notice.
Shares are issued under existing S-3 registration statement (File No. 333-284217) effective Jan 22, 2025.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.